Pharma Trials
Brain Resource offers a standardized platform approach to Marker Discovery
Succeed or Fail-fast
Whether you are a Pharmaceutical company investigating the safety, efficacy and unique advantages of your CNS compound or a Clinical Research organization looking for reliable markers of any teatment's efficacy, a platform approach can help you succeed the rigors of clinical trial validation and bring your solutions for brain health to market sooner.
Brain Resource offers an integrated and systematic evaluation of your solutions’s biological and behavioural impact on cognition and brain function so that you have a greater chance of identifying those assets most likely to succeed and those most likely to fail at later phases of clinical development. Brain Resource can do more than provide automated tests, it provides:
-
a standardized testing platform for all brain health solutions,
-
new analysis methods (including FFT, Loreta and biophysical modelling to elucidate mechanism of action) and
-
access to the Brain Resource International Database to examine how representative your subjects are of your target sample
-
access to the Brain Resource International Database to examine the interrelationships between measures and the relevance of your findings.
The Brain Resource International Database in your trial:
- Provides evidence based comparisons with healthy and clinical subjects aged 6-90 years
- Provides correlations with biological measures even if you only choose to look at cognition. These correlations often provide valuable insights into mechanism of action
- Helps you determine whether your subjects are approximating the performance of their healthy peer cohorts
- Helps you select the tests that explain the greatest variance or sensitivity to change for a disease state, age group or compound type
-
Contact us if you would like:
- Database insights for optimal trial design,
- Information on determining safety and efficacy in early stage trials,
- to discuss a platform approach for the evaluation of your CNS treatment with a Brain Resource Clinical Trials specialist.
